These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7973685)

  • 1. Risk from low-dose exposures.
    Portier CJ; Lucier GW; Edler L
    Science; 1994 Nov; 266(5188):1141-2. PubMed ID: 7973685
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk from low-dose exposures.
    Zendzian RP
    Science; 1994 Nov; 266(5188):1142-3. PubMed ID: 7973686
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk from low-dose exposures.
    Strauss BS
    Science; 1994 Nov; 266(5188):1143-4. PubMed ID: 7973688
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk from low-dose exposures.
    Monro AM
    Science; 1994 Nov; 266(5188):1141. PubMed ID: 7973684
    [No Abstract]   [Full Text] [Related]  

  • 5. Receptor-mediated biological processes: implications for evaluating carcinogens.
    Silbergeld E
    Prog Clin Biol Res; 1994; 387():273-93. PubMed ID: 7972252
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk assessments of low-level exposures.
    Abelson PH
    Science; 1994 Sep; 265(5178):1507. PubMed ID: 7832844
    [No Abstract]   [Full Text] [Related]  

  • 7. A molecular approach to cancer risk.
    Stone R
    Science; 1995 Apr; 268(5209):356-7. PubMed ID: 7716533
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer risk assessment: historical perspectives, current issues, and future directions.
    Velazquez SF; Schoeny R; Rice GE; Cogliano VJ
    Drug Chem Toxicol; 1996 Aug; 19(3):161-85. PubMed ID: 8933022
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk assessments of low-level exposures.
    Smith SJ; Chen AT; Caudill SP; Wetterhall SF; Sever LE
    Science; 1995 Feb; 267(5198):603-4. PubMed ID: 7839131
    [No Abstract]   [Full Text] [Related]  

  • 10. A proposed framework for assessing risk from less-than-lifetime exposures to carcinogens.
    Felter SP; Conolly RB; Bercu JP; Bolger PM; Boobis AR; Bos PM; Carthew P; Doerrer NG; Goodman JI; Harrouk WA; Kirkland DJ; Lau SS; Llewellyn GC; Preston RJ; Schoeny R; Schnatter AR; Tritscher A; van Velsen F; Williams GM
    Crit Rev Toxicol; 2011 Jul; 41(6):507-44. PubMed ID: 21591905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative risk assessment and the limitations of the linearized multistage model.
    Lovell DP; Thomas G
    Hum Exp Toxicol; 1996 Feb; 15(2):87-104. PubMed ID: 8645508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-mediated events and the evaluation of the Environmental Protection Agency (EPA) of dioxin risks.
    Sewall CH; Lucier GW
    Mutat Res; 1995 Dec; 333(1-2):111-22. PubMed ID: 8538618
    [No Abstract]   [Full Text] [Related]  

  • 14. To MTBE or not to MTBE.
    Environ Health Perspect; 1994 Nov; 102(11):913. PubMed ID: 9766950
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing cancer risks from short-term exposures in children.
    Ginsberg GL
    Risk Anal; 2003 Feb; 23(1):19-34. PubMed ID: 12635720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant shortcomings of the U.S. Environmental Protection Agency's latest draft risk characterization for dioxin-like compounds.
    Starr TB
    Toxicol Sci; 2001 Nov; 64(1):7-13. PubMed ID: 11606796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A regulatory view on the article: Risk evaluation of carcinogens and their threshold levels, part I-III].
    Dieter HH; Konietzka R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Sep; 49(9):921-5. PubMed ID: 16953360
    [No Abstract]   [Full Text] [Related]  

  • 18. Polychlorinated dibenzo-para-dioxins.
    IARC Monogr Eval Carcinog Risks Hum; 1997; 69():33-343. PubMed ID: 9336729
    [No Abstract]   [Full Text] [Related]  

  • 19. How serious is dioxin's cancer risk?
    Cooney CM
    Environ Sci Technol; 2001 May; 35(9):180A-181A. PubMed ID: 11355197
    [No Abstract]   [Full Text] [Related]  

  • 20. [What is the understanding of the scientific basis and the regulatory toxicology associated with the term "not appreciable " in the risk evaluation of carcinogens].
    Dieter HH; Konietzka R; Neumann HG
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Aug; 50(8):1084-5. PubMed ID: 17676413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.